Attention Shoppers And Investors: ChromaDex Makes Tru Niagen Available At Walmart
Executive Summary
Tru Niagen products available at 3,800 US Walmart stores include a lower dose, 100 mg, that ChromaDex didn't previously market. Launch sparks heavy trading driving up firm's share price.
Walmart customers are seeing ChromaDex Corp.’s Tru Niagen supplement on shelves for the first time, while investors saw the launch as a prompt to trade ChromaDex shares.
The Tru Niagen products that customers are finding at 3,800 US Walmart stores as of 7 June includes a variety of the supplement made with its proprietary nicotinamide riboside that ChromaDex doesn’t provide for any other retailer or distributor.
The firm is providing Walmart, the first major US retailer to carry its products, with 100-mg Tru Niagen, priced at $19.97 for 30, rather than the 300- and 500-mg formulations it had distributed previously. It’s also providing Walmart a 300-mg product, $42.97 for 30.
Both dose sizes are available at Walmart in packaging that differs from ChromaDex’s regular design; they’re also available online with same-day delivery and in-store pickup options at some locations.
Los Angeles-based ChromaDex says Niagen, its branded ingredient it provides for use in other firm’s products, is a form of vitamin B3 clinically proven to elevate nicotinamide adenine dinucleotide (NAD+) to reduce the impact of aging and daily wear and tear on the body.
Studies of NAD+, a coenzyme naturally produced in the body, have shown it declines up to 50% between ages 40 and 60, according to ChromaDex. With daily 300-mg supplementation, Niagen can increase NAD+ 40% to 50%, it says.
Along with its most recent quarterly results, the firm in March announced an agreement to offer a lower dose of Tru Niagen at a lower price at Walmart stores in the US. (Also see "ChromaDex To Offer Lower-Dose Tru Niagen At Lower Price In US Walmart Stores" - HBW Insight, 11 Mar, 2021.)
Expanding distribution to Walmart also should do the same for the Tru Niagen target market beyond consumers who use it specifically for aging or for fitness or energy metabolism.
The firm's announcement got investors' attention, with its share price jumping nearly 6% in early trade to $10.30 after closing at $8.94 on 4 June. In trading at more than twice the stock's average volume on NASDAQ, the share price closed up 2.68% at $9.18.